In addition to its role as a potent antioxidant, vitamin E is involved in a wide range of physiological processes, ranging from immune function and control of inflammation to regulation of gene expression and cognitive performance. Results from multiple studies suggest that poor nutritional status and higher prevalence of other oxidative stressors such as malaria and HIV infection predispose populations in developing countries for vitamin E deficiency. Although direct comparison between study outcomes is complicated by varied definitions of vitamin E deficiency, data trends indicate that children and the elderly are more vulnerable age groups and that men may be at higher risk for deficiency than women. Public health initiatives aimed at improving the vitamin E status of high-risk populations in developing countries would be prudent to counteract oxidative stress, improve immune function, and protect against neurologic and cognitive deficits. Additional research is needed to establish dose-response relationships of various interventions and to develop cost-effective, culturally-appropriate, and targeted programs.
Introduction
As the diverse roles of vitamin E in the maintenance of health and the prevention of disease become elucidated, the extensive implications of its deficiency are increasingly evident. In addition to its role as a potent antioxidant, vitamin E is involved in physiological processes ranging from immune function and control of inflammation to regulation of gene expression and cognitive performance. Deficiency of vitamin E is characterized by peripheral neuropathy, ataxia, and anemia. Populations in developing countries may be at greater risk for deficiency due to limited intake of food sources of the vitamin and higher prevalence of oxidative stressors such as malaria and HIV infection, which accelerate its depletion. This review provides a summary of vitamin E sources, functions, and requirements, presents evidence for the health consequences of vitamin E deficiency, considers risk factors for deficiency in the developing country context, examines prevalence estimates of deficiency reported in developing countries, and provides recommendations for public health initiatives to improve the vitamin E status of vulnerable populations.
Background Forms and bioavailability
The vitamin E family is composed of four tocopherols (α, β, γ, and λ) and four tocotrienols (α, β, γ, and λ) that differ from one another in the degree and site of methylation in the chromanol ring and the configuration of the methyl groups in the side chains [1] . The structures of the eight isoforms are shown in figure 1 [2] .
The most abundant form of vitamin E found in human tissues is α-tocopherol. Naturally occurring α-tocopherol in foods is the RRR-or d-stereoisomer, while synthetic or all-rac-α-tocopherol is a mixture of eight stereoisomers. Because only the four 2R-αtocopherol isomers are efficiently retained in the human body [3] , synthetic α-tocopherol is less biologically active than the natural form. Several studies conducted in humans with and without aberrations in vitamin E metabolism have concluded that stereoisomers and isoforms of vitamin E are equally absorbed and secreted in chylomicrons. However, verylow-density lipoprotein (VLDL) is preferentially enriched with RRR-α-tocopherol, explaining the higher plasma concentrations of this form [4] [5] [6] [7] . Evidence from a kinetic modeling study of radiolabeled RRR-and all-rac-α-tocopherol administered to a single subject in a crossover design showed that peak plasma 14 C concentration was 1.86 times greater from RRR-than that from all-racα-tocopherol [8] .
The form of vitamin E present in the greatest amounts in the human diet is γ-tocopherol; however, the concentration of γ-tocopherol in tissue is generally 10 times lower than that of α-tocopherol. This discrepancy is related to preferential retention of α-tocopherol due to higher affinity for the α-tocopherol transport protein (α-TTP) and preferential catabolism of γ-tocopherol to its carboxy ethyl hydroxyl chroman (CEHC) metabolite [9] [10] . Despite its lower physiological concentrations, research has indicated that γ-tocopherol may serve an important functional role in the human body. It surpasses α-tocopherol in detoxifying lipophilic electrophiles, possesses anti-inflammatory properties, generates the metabolite γ-CEHC that facilitates natriuresis, and may protect against cardiovascular disease and prostate cancer [11] .
Absorption and metabolism
All naturally occurring isoforms of vitamin E are absorbed in the presence of dietary fat, bile, and pancreatic secretions, with bioavailability influenced by the amount of fat and food matrix [12] . The proportion of ingested vitamin E absorbed in humans is estimated to range from 33% to 68% [9] . Bound in micelles formed within the intestine, vitamin E is passively absorbed into enterocytes and incorporated into chylomicrons that are secreted into the lymph [13] [14] . Lipoprotein lipase (LPL) hydrolyzes the chylomicrons to release vitamin E to tissues such as muscles, adipocytes, and brain [1] . As chylomicron remnants are formed, surface components including some vitamin E are preferentially transferred to highdensity lipoproteins (HDLs) and subsequently to other lipoproteins in the circulation.
Vitamin E is taken up into the liver via lipoproteins and chylomicron remnants. In the liver, the α-TTP selectively salvages RRR-α-tocopherol and facilitates its incorporation into VLDLs, possibly with assistance from other transport proteins, including ATP-binding cassette protein A1 (ABCA1) [15] . Following release of VLDL from the liver, α-tocopherol is redistributed to other lipoproteins for transport to the peripheral tissues. Although adipocytes and skeletal muscle have the capacity to accumulate vitamin E, mobilization from these tissues to maintain plasma concentration is not strongly influenced by dietary deficiency, exercise, or weight loss [16] [17] .
Excess α-tocopherol and other vitamin E isoforms in the liver are excreted into bile directly via a multidrugresistance gene product (MDR2) or indirectly following metabolism to CEHCs by a cytochrome P450-mediated process. CEHCs are also excreted in urine. Because release of vitamin E from tissue storage is a slow process with poorly understood control mechanisms, excretion is an important factor in the regulation of circulating concentrations [9] . 
Functions Antioxidant
Vitamin E is a lipid-soluble chain-breaking antioxidant that scavenges free radicals to protect cell membranes and lipoproteins from oxidative damage. In the presence of free metals such as iron or copper, lipid hydroperoxides (ROOH) are oxidized to peroxyl radicals (ROO·). Peroxyl radicals react 1,000 times faster with α-tocopherol than with polyunsaturated fatty acids (PUFAs), preventing further oxidation [18] . The tocopheroxyl radical then reacts with hydrogen donors such as vitamin C or glutathione to return vitamin E to its reduced state [9] .
Immune regulator
Evidence from animal and human studies suggests a role of vitamin E in the immune system, with even marginal deficiency impairing the immune response [19] . Two randomized, controlled trials found that supplementation with vitamin E improved immune function in elderly nursing home residents [20] [21] .
Although the mechanism has not been fully elucidated, vitamin E appears to reduce age-associated defects in T-cell function both directly and indirectly by moderating production of the T-cell suppressive factor PGE 2 by macrophages [22] . In relation to viral infections, it has been proposed that antioxidant nutrient deficiency may not only compromise the host immune system, but also lead to enhanced viral mutation rate through direct oxidative damage of viral genes [23] .
Novel functions
More recently, vitamin E has been ascribed a diverse range of functions. The novel roles of vitamin E include regulation of signal transduction via membrane-bound or recruited enzymes, regulation of gene expression, activity as a redox sensor, participation in cellular trafficking, and control of inflammation [24] [25] . In the domain of cardiovascular health, α-tocopherol has been shown to inhibit smooth-muscle cell proliferation [26] , endothelial dysfunction [27] , and platelet aggregation [28] via protein kinase C-dependent mechanisms. However, clinical trials of α-tocopherol for the prevention of cardiovascular disease have yielded largely negative results [1] . In the elderly, vitamin E status has been positively associated with cognitive function, physical performance, and longevity [29] [30] [31] [32] [33] [34] .
Vitamin E requirements
The Dietary Reference Intakes (DRIs) for vitamin E were revised by the Food and Nutrition Board of the Institute of Medicine in 2000. The Recommended Daily Allowance (RDA) for vitamin E in each age group was calculated as the Estimated Average Requirement (EAR) plus twice the assumed coefficient of variation of 10% due to lack of information on the standard deviation of the requirement for vitamin E. In adults, the EAR is set at 12 mg/day of RRR-α-tocopherol on the basis of studies conducted in men demonstrating that this intake limited hydrogen peroxide-induced erythrocyte hemolysis to < 12%. Parallel data were not available for women, but it was assumed that although total body weight is lower in women than in men, the larger percentage of body weight as fat mass would lead to similar requirements for vitamin E. In children, the EAR and RDA were extrapolated from adult data accounting for lean body mass and needs for growth [2] . The current DRIs by age group and physiological state are listed in table 1. It is notable that these recommendations are aimed at the prevention of symptomatic deficiency rather than health promotion or disease prevention, in part because of the paucity of evidence that higher intakes of vitamin E reduce the risk of disease.
Dietary sources
Major dietary sources of α-and γ-tocopherols include vegetable oils, nuts, whole grains, and green leafy vegetables. All eight isoforms of vitamin E occur naturally in foods but in differing amounts. The contents of α-and γ-tocopherol found in major dietary sources, as estimated by the US Department of Agriculture (USDA) National Nutrient Database, are listed in table 2 [35] . Although the USDA database reports both α-and γ-tocopherol contents of many foods, food composition tables from other countries often report total vitamin E or α-tocopherol contents only. In some countries, nutrient databases do not include estimates of vitamin E from food sources. Table 3 summarizes the vitamin E information provided by a variety of national and regional food composition tables available through the Food and Agriculture Organization (FAO) of the United Nations [36] .
Assessment of status
Plasma or serum α-tocopherol is the most widely used biomarker of vitamin E status [37] , partially because of the practicality of its use in large surveys and the field setting. However, confounding factors, including age, sex, plasma lipids, lipid-lowering drugs, and smoking, affect the accuracy of this indicator [38] . Circulating α-tocopherol levels are highly correlated with levels of blood lipids, especially of cholesterol, so the ratios of α-tocopherol to plasma lipids or cholesterol alone are often considered more meaningful indicators of status in healthy individuals. Because serum cholesterol was among the strongest predictors of serum α-tocopherol in the third National Health and Nutrition Examination Survey (NHANES III, 1988-1994), the α-tocopherol:total cholesterol ratio has been considered the preferred measure of vitamin E status [39] [40] . In subjects with altered lipid levels due to liver disease or other health conditions, it is valuable to present both absolute α-tocopherol and the α-tocopherol:lipid ratio for optimal assessment of status. Despite its value as a biomarker, plasma or serum α-tocopherol is not well correlated with dietary intake [2] . Platelet α-tocopherol concentration is considered a more sensitive indicator of dietary vitamin E intake on the basis of a better dose-response relationship and absence of influence by plasma lipids [41] , but it is not a practical measurement for fieldwork.
Vitamin E deficiency

Defining deficiency
According to the Food and Nutrition Board of the Institute of Medicine, vitamin E deficiency in normal, healthy adults is defined by a plasma α-tocopherol concentration < 12 μmol/L (0.5 mg/dL) based on the association of greater concentrations with normal in vitro hydrogen peroxide-induced erythrocyte hemolysis [2] . However, studies of vitamin E status in diverse populations have used cutoffs ranging from 2.8 to 24 μmol/L (0.1 to 1.0 mg/dL) to define deficiency and insufficiency (table 4). Notably, data from NHANES 1999/2000 showed that although only 0.5 ± 0.1% of adults over age 20 were deficient according to the above definition (serum α-tocopherol < 11.6 μmol/L [0.5 mg/dL]) [42] , 89.8% of men and 96.3% of women 19 years of age or older in the same survey had usual α-tocopherol intakes under the EAR [43] . This discrepancy urges caution in the interpretation of circulating α-tocopherol as an indicator of status and also draws attention to the limitations of the evidence upon which intake requirements are based.
There is some evidence suggesting that normal concentrations of plasma α-tocopherol are lower in pediatric populations and higher during pregnancy [37, [44] [45] [46] . In a study of 39 healthy children aged 1 to 12 years and adults, the mean plasma α-tocopherol level was 13.8 μmol/L (0.59 mg/dL) in children compared with 18.3 μmol/L (0.79 mg/dL) in adults. Although 36% of the pediatric population studied had plasma concentrations < 11.6 μmol/L (0.5 mg/dL), none of these subjects had excessive in vitro hydrogen peroxideinduced erythrocyte hemolysis. The authors concluded that 7 to 21 μmol/L (0.3 to 0.9 mg/L) α-tocopherol is a normal range for children [44] . During pregnancy, blood α-tocopherol concentrations increase in association with blood lipids [47] ; however, an alternative reference range of normalcy for different stages of pregnancy has not been established.
In studies reporting the ratio of α-tocopherol to total lipids (cholesterol and triglycerides) or cholesterol alone, the lower limits of the normal range are 1.6 to 2.4 μmol of α-tocopherol:mmol lipid or 2.2 to 2.5 μmol α-tocopherol:mmol cholesterol. Although use of these indices may prevent overestimation of vitamin E deficiency in developing countries where serum lipid levels can be low, their interpretation is complicated by altered lipid metabolism of severe protein-energy malnutrition (PEM). Unlike mild undernutrition, PEM is characterized by elevated circulating triglycerides and fatty liver, possibly related to an inability of tissue or plasma triglycerides to undergo lipolysis due to the unavailability of sufficient protein for synthesis of lipolytic enzymes [48] . Furthermore, α-tocopherol may become trapped in triglyceride-rich lipoproteins that cannot be effectively catabolized. For these reasons, in the developing country context it is valuable to consider both absolute and adjusted circulating α-tocopherol concentrations.
Symptoms of deficiency
While overt vitamin E deficiency in humans is rare, causes include severe malnutrition, fat malabsorption syndromes (cystic fibrosis, cholestatic liver disease, and intestinal resection), genetic defects affecting α-TTP or lipoprotein synthesis, and some hematologic disorders (β-thalassemia major, sickle-cell anemia, and glucose-6 phosphate dehydrogenase deficiency) [1] . Severe malnutrition may result in deficiency due to limited intakes of dietary vitamin E and protein necessary for α-TTP synthesis [9] . Symptomatic vitamin E deficiency has not been reported in healthy individuals consuming diets low in vitamin E [17] .
In various species of animals depleted of vitamin E, described symptoms of deficiency have included necrotizing myopathy, fetal death and resorption, anemia, and tissue accumulation of lipofuscin, a pigment associated with aging [49] . In humans, clinical vitamin E deficiency is characterized by progressive peripheral neuropathy, ataxia, muscle weakness, retinal damage leading to blindness (retinitis pigmentosa), infertility, and dementia [1, 17, 50] . Individuals with autosomal recessive mutations in the gene for α-TTP (ataxia with vitamin E deficiency [AVED]) present with neurodegenerative symptoms including cerebellar ataxia, loss of deep tendon reflexes, vibratory-sense disturbances, dysarthria, muscle weakness, head titubation, and dystonia [51] .
Acanthocytosis, a characteristic alteration of the erythrocyte membrane morphology, is associated with vitamin E deficiency and results in increased erythrocyte hemolysis and anemia. It is likely that the peripheral neuropathy and anemia seen in vitamin E deficiency are caused by excessive free radical damage to the large-caliber axons in sensory neurons and to the erythrocyte membrane, respectively [18] . Plasma α-tocopherol concentrations < 8 μmol/L are associated with neurologic disease in humans [52] [53] , while concentrations < 12 μmol/L are associated with increased red blood cell fragility in vitro [2] .
Risk factors for deficiency
In addition to dietary intake and conditions of oxidative stress, the risk of vitamin E deficiency may be influenced by age, obesity, and sex. Historically, children have been the population in which vitamin E deficiency due to underconsumption is most frequently observed [18] . A study of dietary intake of toddlers aged 18 to 30 months in Egypt, Kenya, and Mexico estimated that the mean daily vitamin E intake was inadequate in all groups [54] . In some elderly populations, low dietary diversity and poor fruit and vegetable intake may contribute to poor antioxidant vitamin status [55] [56] . The observation that vitamin E deficiency is often accompanied by low circulating levels of other antioxidants, including vitamin C and β-carotene, supports the theory that deficiencies are associated with poor intake and greater oxidative stress.
Among adolescents and adults, obesity and male sex may predispose individuals to vitamin E deficiency. An association between obesity and poor vitamin E status has been demonstrated in multiple studies [55, [57] [58] [59] , possibly due to sequestration of α-tocopherol in adipose tissue [60] . Many studies conducted in developing and developed countries have shown a greater risk of vitamin E deficiency in men than in women [56, [61] [62] [63] . Although the cause of the discrepancy is poorly understood, contributing factors may include greater intake of PUFAs, more frequent smoking and alcohol consumption, and higher prevalence of heart disease in men. Alternatively, the discrepancy may be explained in part as an artifact of using the same cutoffs for deficiency in men and women.
Vitamin E deficiency in developing countries
Additional influences on vitamin E status
In developing countries, prevalent conditions including malnutrition, malaria, and HIV infection may compromise vitamin E status and raise intake requirements. In PEM, chronic underconsumption of vitamin E leads to depletion of α-tocopherol in target tissues. Vitamin E deficiency may be exacerbated by limited ingestion of protein necessary for synthesis of hepatic α-TTP. In a study that compared Indian children with PEM according to weight-for-age criteria with age-matched healthy controls, Kalra et al. found significantly lower mean serum α-tocopherol concentrations (6.0 ± 2.6 μmol/L compared with 9.5 ± 2.1 μmol/L in controls) and a significantly higher prevalence of neurologic deficits in the children with PEM [52] . After 6 weeks of supplementation with 100 mg/kg/day of α-tocopherol in aqueous solution, children with PEM had a significant increase in serum α-tocopherol and significant improvement in a variety of neurologic tests [53] .
Malaria is endemic in parts of Asia, Africa, and Central and South America, causing an estimated 500 million episodes of infection annually [64] . Compromise of vitamin E status during malarial infection may be mediated by hepatic cell apoptosis caused by increased oxidative stress. Besides depleting plasma α-tocopherol and other plasma antioxidants directly, subsequent hepatic dysfunction may reduce the secretion of α-tocopherol from the liver [65] . A study of Indian children aged 2 to 11 years comparing plasma α-tocopherol concentrations in healthy controls with the concentrations in children with mild or severe malaria found significant differences in vitamin E status according to the severity of malarial infection. The median plasma α-tocopherol concentrations in controls and in children with mild and severe infection were 17.7, 11.5, and 7.3 μmol/L, respectively [66] . Mean serum α-tocopherol was found to increase significantly from 7.6 ± 2.6 to 8.6 ± 2.6 μmol/L in a group of Ugandan children aged 1 to 10 years after 7 days of treatment for acute malaria [67] .
Like malaria, HIV is highly prevalent in developing countries. Of the estimated 33 million people living with HIV globally, approximately 67% are in sub-Saharan Africa [68] . HIV-positive patients have increased oxidative stress biomarkers and lower plasma antioxidants compared with healthy volunteers. Allard et al. found significantly lower mean plasma α-tocopherol concentrations in Canadian HIV-positive patients (22.5 ± 1.2 μmol/L) than in seronegative controls (26.6 ± 2.6 μmol/L) [69] . Supplementation of HIVinfected subjects with vitamin E was found to decrease both oxidative stress and viral load [70] [71] .
Prevalence of vitamin E deficiency
Because of the wide variation in the biomarkers and cutoffs used to define vitamin E deficiency, direct comparison of the prevalence of inadequacy in studied populations is not possible. Nevertheless, these data provide an indication of the degree of deficiency as a public health concern and illustrate its geographic, age, and sex distribution. A summary of prevalence studies of vitamin E deficiency in developing countries by age group is presented in table 4.
Geographic distribution
Most population studies of vitamin E status in developing countries have been undertaken in Asia and Africa, with a limited number in Central and South America and the Middle East. The reported prevalence of deficiency has ranged from approximately 20% to 90%, in large part due to variations in definitions of adequacy as well as in study design and target populations. Several studies have presented deficiency prevalence using alternative cutoffs, resulting in substantially different estimates.
Vitamin E deficiency prevalence estimates in children in different parts of the world are heavily influenced by the choice of cutoff. A study of 262 Bedouin children aged 0.5 to 5.5 years in Jordan found 17.1% and 89.2% of the study subjects to be vitamin E deficient with the use of serum α-tocopherol < 11.6 μmol/L and < 17.2 μmol/L as respective cutoffs [72] . On the basis of work by Farrell et al. showing lower normal levels of circulating α-tocopherol in children (7 to 21 μmol/L ) [44] , it can be argued that the prevalence of deficiency in children was overestimated even with the lower cutoff. A study of 284 schoolgirls aged 7 to 9 years in rural and urban communities of southern Vietnam estimated the prevalence of vitamin E deficiency to be 20.0% and 27.1% in rural and urban areas, respectively, according to a cutoff of serum α-tocopherol < 4.8 μmol/L, but 100% in both areas according to a cutoff of serum α-tocopherol:total lipid < 2.36 μmol/mmol. Dietary intake was assessed by 24-hour recall; however, tocopherol is not included in the Nutritive Composition Table of Vietnamese Foods, and the estimated intake was therefore not calculated [73] . It is likely that the substantial differences in deficiency prevalence estimates reported in this study were due to a relatively low cutoff for serum α-tocopherol and a generous cutoff for α-tocopherol:total lipid, revealing that such estimates are heavily dependent on definitions.
Other studies conducted in children have used a single definition of deficiency, although the choice of cutoff similarly affected the estimated prevalence. In Korea, the prevalence of vitamin E deficiency in 131 children aged 2 to 6 years was estimated at 67% with a cutoff of plasma α-tocopherol < 12 μmol/L; however, the authors noted that none of the subjects had concentrations < 7 μmol/L [74] . In a multicenter study of 336 HIV-infected or HIV-exposed children aged 1 to 3 years in Brazil, Argentina, and Mexico, the choice of plasma α-tocopherol < 18 μmol/L as a cutoff resulted in a high estimated prevalence of deficiency (89%), in concordance with the Jordanian study described previously. The median plasma α-tocopherol concentrations were 12.42 (range, 3.34 to 44.75) and 11.38 (range, 3.66 to 27.65) μmol/L in HIV-infected and HIV-exposed groups, respectively, revealing that the estimated prevalence would have been considerably lower with a more conservative cutoff. The study failed to include a control group without HIV infection or exposure [75] .
The lack of a clear trend in severity of deficiency by region, latitude, or climate, despite the variation in cutoffs used, suggests that the prevalence is more strongly influenced by culture, lifestyle, and presence of infectious disease. Contributing factors may include overall food availability, vitamin E contents of local dietary staples, accessibility and cost of fruits and vegetables, and prevalence of malaria and/or HIV infection.
Age distribution
The majority of studies of the prevalence of vitamin E deficiency in developing countries have focused on children (newborn to 19 years) and the elderly (≥ 60 years), the populations considered to be at higher risk for deficiency. Only a few studies have investigated vitamin E status in mixed-age populations, with some being specific to pregnant or postpartum women.
Most investigations of vitamin E status in childhood have included children within a specific age range, precluding identification of periods of higher risk. The studies involving the largest age ranges were conducted by Fazio-Tirrozzo et al. among girls aged 10 to 19 years in Malawi and by Wetherilt et al. among children aged 7 to 17 years in Turkey. The former investigators found that the prevalence of deficiency was highest in girls aged 14 to 16 years, although the prevalence in this group did not differ significantly from the prevalence in the older and younger age groups. Of the 118 girls studied, 13.9% were wasted (body mass index below the second centile for age) and 33.9% were stunted (heightfor-age below the second centile), possibly indicating chronic energy deficiency. None of the girls who were wasted had an α-tocopherol:cholesterol ratio within the normal range. Additionally, 15.9% of the girls had positive blood smears for malaria and 20% reported blood in the urine, indicative of urinary schistosomiasis, which is endemic to the area [76] . Because the age distributions of wasting, stunting, malaria, and bloody urine were not reported, it is difficult to interpret whether these factors contributed to the higher prevalence of vitamin E deficiency (serum α-tocopherol < 11.6 μmol/L) in girls aged 14 to 16 years. In Turkey, the investigators failed to find an association between vitamin E status and age among the children. In this study, the nutritional status of children from different regions of the country living in cities, small towns, and villages was compared. Plasma α-tocopherol was associated with level of urbanization and region, possibly obscuring an effect of age [77] . Other investigators have not reported prevalence rates within subgroups of the age range studied. Although the use of cutoffs equivalent to those in adult populations may have led to overestimation of vitamin E deficiency in many studies of children, on the basis of the available data vitamin E deficiency is a significant concern among children of all ages in the populations studied.
In a mixed-age population study, Gouado et al. demonstrated a nonstatistically significant improvement in vitamin E status with age from 3 to 61 years in a rural population of northern Cameroon. The subjects in this study were recruited from two neighboring villages. Interestingly, the prevalence of severe vitamin E deficiency (serum α-tocopherol < 5.8 μmol/L) differed significantly between the study villages, with 10 subjects (21.7%) severely deficient in one village and no subjects severely deficient in the other. In contrast, the prevalence of "low" status, defined as serum α-tocopherol 5.8 to 11.6 μmol/L, did not differ significantly by village [78] . Obeid et al. found a significant positive correlation between vitamin E status and age in a Lebanese population aged 25 to 64 years. However, the correlation was no longer present when vitamin E status was expressed as the α-tocopherol:cholesterol ratio [79] . The overall prevalences of deficiency across age groups were considerably higher in northern Cameroon than in Lebanon with the use of either 5.8 or 11.6 μmol/L as a cutoff for α-tocopherol; the difference is likely to be related to differences in dietary intake, socioeconomic status, and environmental stressors.
Although individuals over the age of 60 years are theoretically at higher risk for deficiency, considerable variability in definitions of deficiency in published studies of the elderly in developing countries (< 2.8 to < 14 μmol/L) makes comparison of the results challenging [55] [56] 63] . A study of 235 South Africans aged 60 to 93 years used two alternative but highly conservative cutoffs of < 2.8 and < 3.7 μmol/L of serum α-tocopherol. Mean serum α-tocopherol measured by HPLC in this study was 4.8 ± 2.6 μmol/L, so that the prevalence rates of deficiency were 20.9% and 37.1% according to the respective cutoffs [55] . The considerably lower circulating α-tocopherol concentrations measured in this population as compared with other populations may be attributable to poor dietary intake and diversity. Analysis of two 24-hour dietary recalls in a subset of study subjects (n = 139) found vitamin E intakes below the DRI in 96% of women and 95% of men [55] . In contrast, a large study of 2,336 older Thai adults (≥ 60 years) found a prevalence of vitamin E deficiency of 55.5% with the use of a liberal cutoff (plasma α-tocopherol < 14 μmol/L) [56] . A study in 350 rural elderly Malaysians (≥ 60 years) using a more standard adult cutoff of < 12 μmol/L plasma α-tocopherol found a 26.7% prevalence of deficiency [63] . Dietary intakes were not estimated in the Thai study, whereas in the Malaysian study limitations in food composition tables precluded estimation of vitamin E intake. As a result, comparison of the effect of inadequate intake on vitamin E status in the elderly is not possible. In summary, early and advanced age appear to contribute to vitamin E deficiency in populations where dietary intake is insufficient and/or other risk factors exist.
Sex distribution
Among adults, many studies have demonstrated a higher prevalence of vitamin E deficiency in men than in women [56, [61] [62] [63] . In the study of the elderly Thai cohort described above, male sex had an adjusted odds ratio for vitamin E deficiency (plasma α-tocopherol < 14 μmol/L) of 1.279 (95% confidence interval, 1.001 to 1.636) compared with female sex [56] . In an analysis of samples collected from 2,373 elderly Taiwanese individuals during a national nutrition and health survey, the odds ratios for women having α-tocopherol < 11.6 μmol/L or α-tocopherol:cholesterol < 2.8 μg/mg were 0.48 (95% CI, 0.36 to 0.65) and 0.56 (95% CI, 0.38 to 0.81), respectively, compared with men [61] .
However, some studies have found no sex differences in the risk of vitamin E deficiency. Oldewage-Theron et al. found no significant difference between the vitamin E status of men and women in an elderly South African population [55] , and Obeid et al. found that neither mean α-tocopherol nor α-tocopherol:cholesterol differed significantly by sex in a mixed-age Lebanese population [79] . In contrast to results from other studies, Gouado et al. demonstrated that women had a significantly lower vitamin E:triglyceride ratio than men in northern Cameroon [78] . It is possible that this observation may have been due to poor dietary fat content as well as higher nutritional requirements in men than in women.
To date, studies comparing the vitamin E status of men and women have used the same definition of deficiency for both sexes. Whether this practice is justified is unclear. Early studies used to establish the plasma α-tocopherol concentration necessary to limit in vitro hydrogen peroxide-induced erythrocyte hemolysis were conducted in a small sample of men, although the results were generalized to both sexes [80] [81] [82] . Physiological differences in lipid absorption, metabolism, and storage may affect the normal range of α-tocopherol concentrations in women; however, alternative reference values for females have not been investigated. On the basis of the available data, it appears that depressed α-tocopherol concentrations are generally more prevalent in men than in women in developing countries.
Vitamin E intervention studies
To improve the vitamin E status of populations at risk for deficiency, food-based or supplemental interventions must be identified whereby dietary consumption of the vitamin can be augmented effectively. Various forms of vitamin E fortification and supplementation have been evaluated in adult subjects under experimental conditions using both natural (RRR-) and synthetic (all-rac-) α-tocopherol. Food vehicles used for fortification have included milk, orange juice, margarine, and breakfast cereals, with α-tocopherol added in either fat-or water-miscible solutions. Alternatively, some trials have administered capsules of supplemental α-tocopherol in conjunction with low-or high-fat diets.
It is important to note that experimental studies of vitamin E fortification or supplementation have been conducted in developed countries among participants with adequate baseline status (> 20 μmol/L of plasma α-tocopherol); therefore, the results cannot be generalized to developing-country populations. Furthermore, many experimental studies have provided supplementation in doses that exceed those potentially achievable through public health intervention. Nevertheless, the results of these studies provide valuable information about the comparative efficacy of supplementation or fortification modes. A limited number of studies have evaluated plasma α-tocopherol response to vitamin E-specific, multimicronutrient, or food-based interventions in population-based settings in developed and developing countries. Experimental and populationbased studies of interventions with vitamin E are summarized in table 5.
Of note, esterified forms of α-tocopherol (α-tocopheryl acetate or α-tocopheryl succinate) are routinely used in supplements and fortified foods due to their enhanced stability. In healthy individuals, these esters are hydrolyzed and absorbed as efficiently as α-tocopherol [83] . As defined by the Food and Nutrition Board, 1 mg of all-rac-α-tocopheryl acetate is equivalent to 1 international unit (IU) of vitamin E [2] . One milligram or IU of all-racα-tocopheryl acetate contains 0.9 mg of all-rac-αtocopherol, of which 0.45 mg is present as biologically active 2R-α-tocopherol. In contrast, 1 IU of natural RRR-α-tocopheryl acetate is defined as 0.67 mg of [84] . Microdispersion of 200 to 300 IU of α-tocopheryl acetate in milk, regardless of fat content (0.5% or 1%) or type (vegetable oil or milk fat), raised plasma α-tocopherol concentrations 110% above baseline [85] . In a study using a smaller dose of vitamin E in a multiantioxidant-fortified margarine, 31 IU/day raised circulating concentrations by 16% compared with controls [86] .
In comparing various doses of vitamin E in watermiscible (RRR-α-tocopheryl glycol 1,000 succinate) or fat-soluble (RRR-α-tocopheryl acetate) forms, Dimitrov et al. found both single-dose and 28-day multiple-dose treatments with the fat-soluble form to have a significantly more pronounced effect on circulating α-tocopherol [87] . Supplementation with more than 800 IU/day of vitamin E did not appear to further elevate plasma α-tocopherol, although supplementation at this dose was more effective in the presence of a high-fat diet [87] [88] .
Population-based trials
A small number of population-based trials have found a significant impact of vitamin E fortification, supplementation, or dietary modification in raising circulating α-tocopherol concentrations. In two trials conducted in children in developing countries, vitamin E included as part of a multimicronutrient powder or chewable tablet (foodlet) administered daily for 6 to 9 months resulted in significant improvement in vitamin E status compared with baseline values and with respective control groups [89] [90] . Vitamin E in the multimicronutrient powder was found to remain stable after 30 minutes of cooking or 10 months of storage [89] . In a study of adults in New Zealand, supplementation with 200 IU/day of RRR-α-tocopherol was more effective at appreciably raising circulating concentrations after 8 weeks than a dietary modification aimed to achieve vitamin E intakes of 30 to 40 mg/day (45 to 60 IU/day), although both interventions led to a significant improvement in plasma α-tocopherol and α-tocopherol:cholesterol ratio by 6 weeks [91] .
Public health implications
With an increasing number of recognized and proposed functions in diverse aspects of physiology, vitamin E is a nutrient essential for achieving and maintaining optimal health. Although overt symptoms of vitamin E deficiency generally do not result from poor dietary intake alone, subclinical inadequacy, as evidenced by low circulating plasma levels, is detrimental to immune function, control of oxidative damage, and cognitive function. To ensure vitamin E adequacy in population groups with a demonstrated prevalence of deficiency or an increased risk of deficiency due to undernutrition, infectious disease, or monotonous diet, public health interventions aimed to improve status are indicated.
Optimal status
There is considerable inconsistency in the definitions of vitamin E deficiency in the literature, suggesting that any cutoff may be an unreliable measure of adequacy. On the basis of available evidence, the expert committee of the Institute of Medicine determined that plasma α-tocopherol concentrations < 12 μmol/L (0.5 mg/dL) indicate deficiency in normal, healthy adults [2] . There is some evidence suggesting that normal circulating α-tocopherol concentrations in children may be lower, possibly related to a parallel lower cholesterol concentration [44, 46, 62] . Additional studies are needed to evaluate appropriate pediatric cutoffs using functional outcomes. Because of the difficulty of using the α-tocopherol:lipid ratio as a biomarker of vitamin E status in malnourished populations of developing countries, and the knowledge that plasma concentrations that are normal in adults are acceptable in children, it seems suitable that public health initiatives target > 12 μmol/L as a goal in all individuals.
Programs and policy
As demonstrated in experimental and populationbased trials, various types of intervention can be effective in enhancing vitamin E status. Depending on population needs and resources, programs may be directed at improving vitamin E status, antioxidant vitamin status, or overall nutritional status. Different potential approaches, including their advantages and disadvantages in developing-country settings, are considered below.
Dietary modification
Dietary staples in most developing countries are poor sources of vitamin E. To achieve better status by dietary modification, other vitamin E-rich foods must be introduced through local cultivation or targeted distribution in conjunction with education about the importance of dietary diversification. Seeds, nuts, peanuts, and certain vegetable oils are good sources of vitamin E that are indigenous or possible to grow in a variety of developing-country settings. For example, in western Africa peanut (groundnut) oil is a significant dietary component with widespread cultivation in rural communities [92] . Increased intake of fruits and vegetables has been shown to improve plasma antioxidant concentrations, including α-tocopherol, after 3 months of consumption by healthy German adults [93] . To our knowledge, no interventions aimed at dietary modification to improve vitamin E status have been carried out in developing countries to date. However, existing evidence suggests that increasing intakes of dietary sources of the vitamin improves vitamin E status [91, 93] , and it is feasible that such an intervention could be targeted at high-risk populations in developing countries.
Fortification
In experimental trials, fortification of foods, including milk, margarine, and breakfast cereals, has proven effective in increasing circulating α-tocopherol concentrations [84] [85] [86] . Microdispersion of α-tocopheryl acetate in a fat emulsion appears to be especially advantageous in terms of nutrient stability and impact on plasma α-tocopherol [84] . While fortification of familiar foods is more likely to be accepted by a target population than either dietary modification or supplementation, its implementation is most practical and cost-effective if the fortificant is added during centralized processing. Because milk, fats, and grains are typically cultivated locally in developing countries, fortification as a means of improving vitamin E status would require evaluation of other food vehicles.
Supplementation
Supplementation of children in developing countries with vitamin E contained in a multimicronutrient powder, tablet, or spread has been piloted effectively in several trials [89] [90] 94] . Focus group discussions conducted in Tamil Nadu, India, revealed that supplement powder is preferred to tablets because the latter are perceived as medicine [89] . Furthermore, vitamin E appears to be less bioavailable when isolated in a capsule than when ingested together with food [84] [85] 88] . Because populations in developing countries with a high prevalence of vitamin E deficiency often suffer from other micronutrient deficiencies, multimicronutrient supplementation is likely to be both beneficial and cost-effective. One gram of multimicronutrient powder containing 30 IU of vitamin E was estimated to cost 0.5 US cents per person per day [89] .
Conclusions
Although data on vitamin E intake in developing countries are limited, results from multiple studies suggest that poor overall nutritional status and higher prevalence of other oxidative stressors, such as malaria or HIV, predispose populations for deficiency. Direct comparison between study outcomes is complicated by widely varying definitions of vitamin E deficiency. However, data trends indicate that children and the elderly are more vulnerable age groups and that men may be at higher risk for deficiency than women. Public health initiatives aimed at improving the vitamin E status of high-risk populations would be prudent to counteract oxidative stress, improve immune function, and protect against neurologic and cognitive deficits. On the basis of available research, supplemental vitamin E appears to be most highly bioavailable when finely dispersed in a fortified food source or as a powder. Although it has not been piloted in a developing country, dietary modification to increase intake of natural sources of vitamin E is an alternative to fortification or supplementation that is likely to be effective in improving vitamin E status. Additional research is needed to establish dose-response relationships of various interventions and to develop cost-effective and culturally appropriate programs targeted at the population groups within developing countries who are at greatest risk for vitamin E deficiency. Furthermore, in order to monitor progress, a consensus must be reached regarding appropriate definitions of vitamin E sufficiency by age, sex, and physiological state.
